Finance
Cooper Companies sets pricing of $350 million senior notes due 2015
Published in Medical Device Law Weekly, March 4th, 2007
The notes offering is part of a previously announced refinancing of the company's existing $750 million syndicated bank credit facility.
The company intends to use the net proceeds of both the notes offering and the new revolving credit facility to repay in full its $250 million term loan and the outstanding borrowings under its existing syndicated bank credit facility.
The notes are not being registered under the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Collaborations
Agreement signed between Ipsen and MSD to comarket Adrovance - Finance
Celera Group reports loss of $0.01 per share - Legal Issues
Third Wave and Stratagene reach out-of-court settlement in patent litigation - Licensing Agreements
Critical Therapeutics licenses rights for vagus nerve stimulation device to Innovative Metabolics - Acute Lymphoblastic Leukemia Prognosis
Reports outline acute lymphoblastic leukemia prognosis study findings from University of Malaya, Department of Paediatrics - Adrenal Cancer
Research from State University of Campinas, Department of Urology provide new insights into adrenal cancer - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
